Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.86%4.2M | 16.67%26.38M | 172.88%15.28M | -49.48%3.31M | 18.14%4.29M | -48.60%3.51M | 7.45%22.61M | -33.87%5.6M | 46.18%6.56M | -18.30%3.63M |
| Cost of revenue | 14.98%4.23M | 6.02%29.88M | 130.72%14.38M | -57.95%3.36M | -7.97%3.46M | -49.04%3.68M | -7.51%28.19M | -49.92%6.23M | 49.35%7.98M | -51.01%3.76M |
| Gross profit | 83.33%-29K | 37.16%-3.5M | 244.13%908K | 96.85%-45K | 732.06%828K | 56.50%-174K | 40.88%-5.58M | 84.13%-630K | -65.93%-1.43M | 95.95%-131K |
| Operating expense | 17.05%5.6M | 30.60%23.32M | 10.19%5.66M | 8.32%5.36M | -2.68%4.98M | -4.11%4.79M | -14.79%17.86M | -4.22%5.13M | -5.82%4.95M | -32.63%5.12M |
| Selling and administrative expenses | -6.18%3.11M | -3.60%16.74M | -11.55%3.1M | -11.39%3.06M | -10.87%3.25M | -7.45%3.32M | -9.69%17.37M | -52.17%3.51M | -14.26%3.45M | -42.70%3.64M |
| -General and administrative expense | -6.18%3.11M | -3.60%16.74M | -11.55%3.1M | -11.39%3.06M | -10.87%3.25M | -7.45%3.32M | -9.69%17.37M | -52.17%3.51M | -14.26%3.45M | -42.70%3.64M |
| Depreciation and amortization | 69.55%2.49M | 34.21%8.06M | 57.11%2.55M | 53.63%2.31M | 17.60%1.73M | 4.41%1.47M | --6M | --1.63M | 21.74%1.5M | 19.29%1.47M |
| -Depreciation | 69.55%2.49M | 34.21%8.06M | 57.11%2.55M | 53.63%2.31M | 17.60%1.73M | 4.41%1.47M | --6M | --1.63M | 21.74%1.5M | 19.29%1.47M |
| Other operating expenses | ---- | 1,252.67%6.57M | ---- | ---- | ---- | ---- | -71.76%486K | ---- | ---- | ---- |
| Operating profit | -13.53%-5.63M | -14.47%-26.82M | 17.61%-4.75M | 15.21%-5.41M | 20.89%-4.15M | 8.00%-4.96M | 22.89%-23.43M | 38.23%-5.76M | -4.27%-6.38M | 51.55%-5.25M |
| Net non-operating interest income (expenses) | -2,786.84%-1.1M | -40.56%784K | -153.85%-99K | 45.00%-33K | -164.29%-37K | -153.33%-38K | 169.18%1.32M | -102.86%-39K | -215.79%-60K | 96.09%-14K |
| Non-operating interest income | ---- | -31.31%994K | ---- | ---- | ---- | ---- | 4.33%1.45M | ---- | ---- | ---- |
| Non-operating interest expense | 2,786.84%1.1M | 63.49%206K | 153.85%99K | -45.00%33K | 164.29%37K | 153.33%38K | -85.92%126K | 95.00%39K | 215.79%60K | -96.09%14K |
| Total other finance cost | ---- | 100.00%4K | ---- | ---- | ---- | ---- | 0.00%2K | ---- | ---- | ---- |
| Net investment income | -97.91%6K | 655.17%483K | -56.10%108K | 337.38%254K | -248.21%-166K | 184.91%287K | -87K | 246K | 70.19%-107K | -83.67%112K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 107.15%118K | -2,199.15%-2.71M | 149.58%589K | 0.00%-1.77M | -92.85%118K | -599.58%-1.65M | -118K | 236K | -15.32%-1.77M | 27.20%1.65M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 1,057.12%24.53M | 0 | 500.88%21.35M | 92.09%-2.56M | 0 | 80.24%-5.33M | ||||
| Less:Impairment of capital assets | ---- | -500.88%-21.35M | --0 | -500.88%-21.35M | ---- | ---- | -85.04%5.33M | --0 | -80.24%5.33M | ---- |
| Less:Write off | ---- | -15.09%-3.18M | ---- | ---- | ---- | ---- | 13.58%-2.76M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -31.11%640K | 306.80%2.39M | -397.96%-3.22M | -10.40%853K | -4.21%1.09M | -21.20%929K | -36.23%588K | 134.22%1.08M | -26.54%952K | -69.11%1.14M |
| Income before tax | -9.78%-5.96M | 103.67%885K | -73.66%-7.37M | 220.18%15.25M | -33.33%-3.14M | -13.17%-5.43M | 60.75%-24.09M | 72.51%-4.24M | 62.34%-12.69M | 57.24%-2.36M |
| Income tax | 0 | -311.86%-411K | -981.82%-1.65M | 133.33%14K | 0 | 0 | 452.73%194K | 219.11%187K | -93.62%6K | 0 |
| Net income | -9.78%-5.96M | 105.34%1.3M | -29.09%-5.72M | 220.01%15.23M | -33.33%-3.14M | -13.14%-5.43M | 60.40%-24.28M | 71.00%-4.43M | 62.42%-12.69M | 57.26%-2.36M |
| Net income continuous operations | -9.78%-5.96M | 105.34%1.3M | -29.09%-5.72M | 220.01%15.23M | -33.33%-3.14M | -13.14%-5.43M | 60.40%-24.28M | 71.00%-4.43M | 62.42%-12.69M | 57.26%-2.36M |
| Noncontrolling interests | -58.25%-1.99M | 140.68%3.34M | -11.41%-1.76M | 281.06%7.08M | 18.76%-1.11M | 6.46%-1.26M | 63.41%-8.21M | 71.28%-1.58M | 67.98%-3.91M | 49.95%-1.37M |
| Net income attributable to the company | 4.87%-3.97M | 87.30%-2.04M | -38.86%-3.96M | 192.81%8.15M | -105.57%-2.03M | -20.79%-4.17M | 58.67%-16.08M | 70.85%-2.85M | 59.28%-8.78M | 64.46%-988K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 4.87%-3.97M | 87.30%-2.04M | -38.86%-3.96M | 192.81%8.15M | -105.57%-2.03M | -20.79%-4.17M | 58.67%-16.08M | 70.85%-2.85M | 59.28%-8.78M | 64.46%-988K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 5.56%-0.0034 | 87.59%-0.0017 | -41.67%-0.0034 | 193.33%0.007 | -112.50%-0.0017 | -20.00%-0.0036 | 58.73%-0.0137 | 71.08%-0.0024 | 59.46%-0.0075 | 66.67%-0.0008 |
| Diluted earnings per share | 5.56%-0.0034 | 87.59%-0.0017 | -41.67%-0.0034 | 193.33%0.007 | -112.50%-0.0017 | -20.00%-0.0036 | 58.73%-0.0137 | 71.08%-0.0024 | 59.46%-0.0075 | 66.67%-0.0008 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.